DelveInsight’s “Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Multiple Sclerosis (MS), historical and forecasted epidemiology as well as the Multiple Sclerosis (MS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Multiple Sclerosis (MS) Market Report:
- The market size of Multiple Sclerosis (MS) was estimated to be USD 22,381 Million in the year 2021
- The prevalence of people affected with Multiple Sclerosis is approximately 2.8 million in the global population
- According to the researchers, the prevalence of Multiple Sclerosis is more in females than in males
- In the year 2021, the prevalent cases of Multiple Sclerosis in the United States were found to be 708,888 cases
- Among the EU-5 countries, Germany had the highest number of prevalent cases of Multiple Sclerosis, which were 212,688 cases in 2021
Request a sample for the Report: https://www.delveinsight.com/sample-request/multiple-sclerosis-market
Key benefits of the report:
- Multiple Sclerosis (MS) market report covers a descriptive overview and comprehensive insight of the Multiple Sclerosis (MS) Epidemiology and Multiple Sclerosis (MS) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Multiple Sclerosis (MS) market report provides insights on the current and emerging therapies.
- Multiple Sclerosis (MS) market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Multiple Sclerosis (MS) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Multiple Sclerosis (MS) market.
Got queries? Click here to know more about the Multiple Sclerosis (MS) Market Landscape
Multiple Sclerosis (MS) Overview:
Multiple Sclerosis (MS) is an unpredictable, autoimmune disease that affects the central nervous system. In Multiple Sclerosis, the body’s own immune system produces cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsible for protecting the nerve fibers. This is often characterized by relapsing episodes of neurologic impairment followed by remissions.
The damaged myelin forms scar tissue (sclerosis). Often the nerve fiber is also damaged. When any part of the myelin sheath or nerve fiber is damaged or destroyed, nerve impulses traveling to and from the brain and spinal cord are distorted or interrupted. There is no single test used to diagnose Multiple Sclerosis (MS). The disease is confirmed when symptoms and signs develop and are related to different parts of the nervous system at more than one interval in time and after other alternative diagnoses have been excluded.
Multiple Sclerosis (MS) Symptoms:
People with Multiple Sclerosis (MS) generally develop symptoms in their late 20s. The common symptoms of Multiple Sclerosis include –
- Loss of vision
- Loss in body power
- A rising sense of numbness in the body
- Experiencing visual and sensory disturbances
- Gait Problems
- Bladder and Bowel syndrome
Multiple Sclerosis (MS) Market
The dynamics of the Multiple Sclerosis (MS) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as, NeuroVax, CNM-Au8, ALKS 8700, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Multiple Sclerosis (MS) Market Landscape
Multiple Sclerosis (MS) Pipeline Therapies:
- Tolebrutinib (SAR442168)
- Evobrutinib/ M2951
- ALKS 8700
- Immune Response BioPharma Inc.
- Clene Nanomedicine
- Merck Healthcare KGaA
- TG Therapeutics, Inc.
- Osmotica Pharmaceutical
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Multiple Sclerosis (MS) Patient Share (%) Overview at a Glance
5. Multiple Sclerosis (MS) Market Overview at a Glance
6. Multiple Sclerosis (MS) Disease Background and Overview
7. Multiple Sclerosis (MS) Epidemiology and Patient Population
8. Country-Specific Patient Population of Multiple Sclerosis (MS)
9. Multiple Sclerosis (MS) Current Treatment and Medical Practices
10. Unmet Needs
11. Multiple Sclerosis (MS) Emerging Therapies
12. Multiple Sclerosis (MS) Market Outlook
13. Country-Wise Multiple Sclerosis (MS) Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Multiple Sclerosis (MS) Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States